Viking Therapeutics (VKTX) had the highest return between March 26, 2023 and April 30, 2023 by a mid-cap US stock, returning 138.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Viking Therapeutics (VKTX) | 3/26/2023 - 4/30/2023 | 138.9% |
Oscar Health (OSCR) | 3/26/2023 - 4/30/2023 | 97.94% |
Burford Capital (BUR) | 3/26/2023 - 4/30/2023 | 87.34% |
Immunitybio (IBRX) | 3/26/2023 - 4/30/2023 | 70.73% |
TG Therapeutics (TGTX) | 3/26/2023 - 4/30/2023 | 66.64% |
Applied Digital (APLD) | 3/26/2023 - 4/30/2023 | 55.34% |
Soleno Therapeutics (SLNO) | 3/26/2023 - 4/30/2023 | 53.46% |
Legend Biotech (LEGN) | 3/26/2023 - 4/30/2023 | 50.25% |
SkyWest (SKYW) | 3/26/2023 - 4/30/2023 | 48.09% |
Nextdecade (NEXT) | 3/26/2023 - 4/30/2023 | 47.28% |
Arcellx (ACLX) | 3/26/2023 - 4/30/2023 | 45.52% |
Arrowhead Pharmaceuticals (ARWR) | 3/26/2023 - 4/30/2023 | 45.48% |
CleanSpark (CLSK) | 3/26/2023 - 4/30/2023 | 44.81% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 3/26/2023 - 4/30/2023 | 44.03% |
Energy of Minas Gerais Co DRC (CIG.C) | 3/26/2023 - 4/30/2023 | 38.24% |
Riot Blockchain (RIOT) | 3/26/2023 - 4/30/2023 | 36.84% |
StoneCo (STNE) | 3/26/2023 - 4/30/2023 | 35.24% |
Iris Energy (IREN) | 3/26/2023 - 4/30/2023 | 35.14% |
Life Time (LTH) | 3/26/2023 - 4/30/2023 | 33.7% |
Madrigal Pharmaceuticals (MDGL) | 3/26/2023 - 4/30/2023 | 32.06% |
Apellis Pharmaceuticals (APLS) | 3/26/2023 - 4/30/2023 | 31.39% |
SLM (SLM) | 3/26/2023 - 4/30/2023 | 29.93% |
New Gold (NGD) | 3/26/2023 - 4/30/2023 | 29.29% |
Crane NXT (CXT) | 3/26/2023 - 4/30/2023 | 27.1% |
Nuvalent (NUVL) | 3/26/2023 - 4/30/2023 | 26.85% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
